A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...

Research at SUNY Potsdam is helping shed new light on a specific protein and how it affects people’s health. Although no ...

AOH-VO, an innovative material for aqueous zinc-ion batteries, offers ultrafast charging and exceptional stability through ...

In this study, doxazosin titration occurred on a monthly basis ... inordinately high rate of CHF in the study population. For example, a blockers increase plasma volume, may increase plasma ...

Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over competitors’ more frequent regimens.

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

CBSE Class 12th Sample Papers 2025: The Central Board of Secondary Education (CBSE) has made available all subject sample papers officially along with solutions for academic year 2024-25 ...